Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.

Weight loss injections: How do drugs like Wegovy and Mounjaro work?

NHS experts report unprecedented demand for the new generation of obesity treatments.

Novo Nordisk's obesity-fighting drugs fatten Denmark's economy

Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.

From fashion to the food industry: 11 ways that weight-loss drugs have changed the world

The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?. For a phenomenon that has such visible results, there is huge ...

World - The Guardian - October 20

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.

Business - CNBC - October 24

Weight loss drugs may help reduce drug and alcohol misuse: Research

Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found ...

Politics - The Hill - October 17

FDA will reconsider decision barring copycat versions of Lilly weight loss drug

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

Politics - The Hill - October 14

Eli Lilly to trial use of weight loss drugs to combat unemployment in UK

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Business - CNBC - October 15

Will weight-loss drugs help jobless get back into work?

Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Weight-loss drugs show promise in tackling opioid and alcohol abuse

Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetes

World - Financial Times - October 17

Weight loss drugs could help patients struggling with addiction, study says

A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.

Weight loss drugs could help with alcohol, opioid addiction, study says

Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.

Weight-loss drugs could be key in lowering US obesity rates – experts

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts. Obesity rates have decreased slightly in the US and while it’s too early to say whether the ...

World - The Guardian - October 18

How will weight-loss drugs change our relationship with food?

The rise of these treatments has major implications for how we think about obesity, says James Gallagher.

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - 14 hours ago

With Novo Nordisk success, is there a "Nokia risk" for Denmark?

Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.

Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients

The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

Business - The Wall Street Journal - October 21

Maine shooting survivors claim Army negligence and FDA's weight-loss drug decision: Morning Rundown

Detroit, TCF Center, 2024 election, Harris in Pennsylvania, Lewiston Maine shooting, Trump rally shooting survivors, giant pandas at National Zoo, Mount Everest

Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.

World - The New York Times - October 15

Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott's continuous glucose monitor Lingo.

Business - CNBC - October 15

Weight-loss drug firm accused of prioritising profits after halting insulin pen production

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners. The pharmaceutical company behind injectable weight-loss drugs has been ...

World - The Guardian - October 16

Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

Business - MarketWatch - October 19

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - October 24

Weight Loss Jabs for Jobs?

Health Secretary says jabs could be given to help people get back into work.

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.

Business - CNBC - October 23

Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Politics - The Hill - October 23

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.

Business - CNBC - 5 days ago

Unemployed could get weight loss jabs to return to work

The health secretary announces trials to explore the effect of weight loss drugs on worklessness.

NHS needs better plan around weight loss jabs, warn experts

Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.

Weight loss jabs not ‘quick fix’ for UK worklessness, health experts warn

Scientists say using the drugs to get people back into work could carry logistical and ethical problems. Weight loss jabs are not a “quick fix” and the health secretary’s plan to use them to help ...

World - The Guardian - October 18

Weight loss jabs for jobless not dystopian, says Wes Streeting

The government is looking into whether weight-loss drugs can help get more people back to work.

Latest in Weight loss drug industry injects wealth into Novo Nordisk home country